Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Moodys
Baxter
Mallinckrodt
Colorcon

Last Updated: June 26, 2022

Investigational Drug Information for Tetrahydrocannabivarin


✉ Email this page to a colleague

« Back to Dashboard

What is the drug development status for Tetrahydrocannabivarin?

Tetrahydrocannabivarin is an investigational drug.

There have been 3 clinical trials for Tetrahydrocannabivarin. The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2014.

The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Diabetes Mellitus, and Alopecia Areata. The leading clinical trial sponsors are GW Research Ltd, Gregory L Smith, MD, MPH, and [disabled in preview].

Recent Clinical Trials for Tetrahydrocannabivarin
TitleSponsorPhase
Androgenetic Alopecia Treatment Using Varin and Cannabidiol Rich Topical Hemp Oil: A Case SeriesGregory L Smith, MD, MPHEarly Phase 1
A Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 DiabetesGW Research LtdPhase 2
GWMD1092 - GWP42003 : GWP42004 Together Plus Alone in Type II DiabetesGW Research LtdPhase 2

See all Tetrahydrocannabivarin clinical trials

Clinical Trial Summary for Tetrahydrocannabivarin

Top disease conditions for Tetrahydrocannabivarin
Top clinical trial sponsors for Tetrahydrocannabivarin

See all Tetrahydrocannabivarin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Moodys
Baxter
Mallinckrodt
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.